Simulated Screening Study for Breast Imaging

Status Completed

Clinical Trial Summary

This is a pilot, simulated breast cancer screening study. The goal of the study is to explore these scanning modalities:

1) Combined digital breast tomosynthesis(DBT)/dual-sides 3 dimensional-automated ultrasound(AUS)

2. Explore the utility of photoacoustic imaging as an adjunct to digital breast tomosynthesis(DBT)/ultrasound(US)alone.

Clinical Trial Description

This is a pilot, simulated breast cancer screening study. In a population enriched with mammographic call-backs, we will study whether:

1) Combined digital breast tomosynthesis(DBT)/dual-sides 3 dimensional-automated ultrasound(AUS)will result in a lower call-back rate than digital breast tomosynthesis(DBT)alone.

2. Explore the utility of photoacoustic imaging as an adjunct to digital breast tomosynthesis(DBT)/ultrasound(US)alone.

This study will compare two new breast imaging systems to digital mammography and hand-held ultrasound that are commonly used to find and evaluate breast masses. Images will be done with digital breast tomosynthesis (DBT) and 3-D automated ultrasound(AUS) which will be done in the breast imaging clinic of the main hospital followed by the second light and ultrasound imaging that will be completed in the research lab. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01807754
Study type	Observational
Source	University of Michigan
Contact
Status	Completed
Phase
Start date	December 2012
Completion date	April 23, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02225470` - Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes	Phase 3
Completed	`NCT01271738` - Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer	N/A
Active, not recruiting	`NCT04132960` - Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis	Phase 2
Completed	`NCT01980823` - Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer	Early Phase 1
Completed	`NCT01218529` - Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors	Phase 2
Completed	`NCT02891681` - Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment	N/A
Terminated	`NCT01498588` - Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer	Phase 2
Completed	`NCT00639171` - Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant
Recruiting	`NCT05582499` - Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy	Phase 1/Phase 2
Completed	`NCT05584644` - A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer
Completed	`NCT00243698` - A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions	N/A
Completed	`NCT00807859` - Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer	Phase 1
Completed	`NCT01118624` - Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer	Phase 2
Recruiting	`NCT00941408` - Biomarker Study of Breast Tumors	N/A
Completed	`NCT00626106` - QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer	Phase 2
Recruiting	`NCT01042379` - I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer	Phase 2
Recruiting	`NCT05976620` - Clinical Study of 18F-FAPI-RGD in Breast Tumors
Terminated	`NCT02472353` - Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer	Phase 2
Terminated	`NCT01194908` - Re-expression of ER in Triple Negative Breast Cancers	Phase 1/Phase 2
Completed	`NCT02296801` - A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer	Phase 2